RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS

Background: Acne Vulgaris (AV) is one of the most common diseases in the field of dermatology and ranks as the eighth most prevalent disease worldwide. Early management of this potentially deforming skin disease may reduce the pathophysiological burden and improve the quality of life of patients. Pu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Esravila Ariya Wibisono, Diah Mira Indramaya, Maftuchah Rochmanti
Formato:	article
Lenguaje:	EN ID
Publicado:	Universitas Airlangga 2020
Materias:	acne vulgaris pharmacotherapy new patients retrospective study Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/c0b807597ed042f38415219b52a3fc0a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c0b807597ed042f38415219b52a3fc0a
record_format	dspace
spelling	oai:doaj.org-article:c0b807597ed042f38415219b52a3fc0a2021-12-02T15:41:20ZRETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS2301-71712541-092X10.20473/jbe.V8I32020.236-245https://doaj.org/article/c0b807597ed042f38415219b52a3fc0a2020-09-01T00:00:00Zhttps://e-journal.unair.ac.id/JBE/article/view/12730https://doaj.org/toc/2301-7171https://doaj.org/toc/2541-092XBackground: Acne Vulgaris (AV) is one of the most common diseases in the field of dermatology and ranks as the eighth most prevalent disease worldwide. Early management of this potentially deforming skin disease may reduce the pathophysiological burden and improve the quality of life of patients. Purpose: This study aimed to determine the pharmacotherapy for new patients with AV. Methods: This cross-sectional study used new patients with AV of the Cosmetic Division of the Outpatient Skin and Venereal Health Unit, Regional Public Hospital (RSUD) Dr. Soetomo, from January to December 2013 that were descriptively presented. The variable was the pharmacotherapy given. This study used secondary data collection by looking at the patients’ medical records. The variables studied were acne lesions and pharmacotherapy regimens, including the administration route and the medicine used. Results: The number of samples that met the inclusion criteria was 951 patients. Comedonal acne was most commonly given topical tretinoin. Papulopustular acne was most commonly given a topical combination of clindamycin and tretinoin, while acne conglobata was most commonly given a combination of topical clindamycin and tretinoin with oral doxycycline. Conclusion: The new patients with comedonal acne were mostly prescribed topical tretinoin pharmacotherapy. A pharmacotherapy combination of topical clindamycin and tretinoin was given to most new patients with papulopustular acne, whereas new patients with conglobata acne were given a pharmacotherapy combination of topical tretinoin and clindamycin with oral doxycycline.Esravila Ariya WibisonoDiah Mira IndramayaMaftuchah RochmantiUniversitas Airlanggaarticleacne vulgarispharmacotherapynew patientsretrospective studyPublic aspects of medicineRA1-1270Infectious and parasitic diseasesRC109-216ENIDJurnal Berkala Epidemiologi, Vol 8, Iss 3, Pp 236-245 (2020)
institution	DOAJ
collection	DOAJ
language	EN ID
topic	acne vulgaris pharmacotherapy new patients retrospective study Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216
spellingShingle	acne vulgaris pharmacotherapy new patients retrospective study Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216 Esravila Ariya Wibisono Diah Mira Indramaya Maftuchah Rochmanti RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
description	Background: Acne Vulgaris (AV) is one of the most common diseases in the field of dermatology and ranks as the eighth most prevalent disease worldwide. Early management of this potentially deforming skin disease may reduce the pathophysiological burden and improve the quality of life of patients. Purpose: This study aimed to determine the pharmacotherapy for new patients with AV. Methods: This cross-sectional study used new patients with AV of the Cosmetic Division of the Outpatient Skin and Venereal Health Unit, Regional Public Hospital (RSUD) Dr. Soetomo, from January to December 2013 that were descriptively presented. The variable was the pharmacotherapy given. This study used secondary data collection by looking at the patients’ medical records. The variables studied were acne lesions and pharmacotherapy regimens, including the administration route and the medicine used. Results: The number of samples that met the inclusion criteria was 951 patients. Comedonal acne was most commonly given topical tretinoin. Papulopustular acne was most commonly given a topical combination of clindamycin and tretinoin, while acne conglobata was most commonly given a combination of topical clindamycin and tretinoin with oral doxycycline. Conclusion: The new patients with comedonal acne were mostly prescribed topical tretinoin pharmacotherapy. A pharmacotherapy combination of topical clindamycin and tretinoin was given to most new patients with papulopustular acne, whereas new patients with conglobata acne were given a pharmacotherapy combination of topical tretinoin and clindamycin with oral doxycycline.
format	article
author	Esravila Ariya Wibisono Diah Mira Indramaya Maftuchah Rochmanti
author_facet	Esravila Ariya Wibisono Diah Mira Indramaya Maftuchah Rochmanti
author_sort	Esravila Ariya Wibisono
title	RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
title_short	RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
title_full	RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
title_fullStr	RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
title_full_unstemmed	RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
title_sort	retrospective study: initial pharmacotherapy profile of new acne vulgaris patients
publisher	Universitas Airlangga
publishDate	2020
url	https://doaj.org/article/c0b807597ed042f38415219b52a3fc0a
work_keys_str_mv	AT esravilaariyawibisono retrospectivestudyinitialpharmacotherapyprofileofnewacnevulgarispatients AT diahmiraindramaya retrospectivestudyinitialpharmacotherapyprofileofnewacnevulgarispatients AT maftuchahrochmanti retrospectivestudyinitialpharmacotherapyprofileofnewacnevulgarispatients
_version_	1718385897359015936

RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS

Ejemplares similares